1 |
Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries |
|
| | Mangat Ram Dogra, Anand Vinekar | | | Pediatric Health, Medicine and Therapeutics. 2023; Volume 14: 59 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population |
|
| | Subhasish Pramanik, Lakshmi Kanta Mondal, Suman Kalyan Paine, Sneha Jain, Subhankar Chowdhury, Upasana Ganguly, Sayantan Ghosh, Chiranjit Bose, Koena Bhattacharjee, Gautam Bhaduri | | | Clinical Ophthalmology. 2021; Volume 15: 3341 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Klebsiella Cluster Endophthalmitis following Intravitreal Bevacizumab: Role of Early Detection, Pars Plana Vitrectomy, and Intracameral Moxifloxacin |
|
| | Gaurav Mohan Kohli, Pratik Shenoy, Pawan Puneet Malhotra, Shubhi Tripathi, Sachin Shetty, Alok Sen | | | Ocular Immunology and Inflammation. 2020; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review |
|
| | Stephanie Lin, Pradeep Ramulu, Ecosse L Lamoureux, Charumathi Sabanayagam | | | Clinical & Experimental Ophthalmology. 2016; 44(4): 300 | | | [Pubmed] [Google Scholar] [DOI] | | 5 |
Translating research into practice |
|
| | Natarajan, S. | | | Indian Journal of Ophthalmology. 2014; 62(1): 1-2 | | | [Pubmed] [Google Scholar] | |
|